Thalidomide

Jul 10, 2019

Revlimid (lenalidomide; Celgene) Drug Overview & Product Profiles 2017-2026: An Oral Thalidomide Analog with Antineoplastic, Immunomodulatory, and Anti-Angiogenic Properties

Jan 09, 2019

Minister of Health announces new financial support program for eligible Canadian thalidomide survivors

Nov 29, 2017

Lenalidomide Market to Grow on Account of Rising Usage in Treatment of Anemia & Multiple Myeloma Diseases till 2021: Million Insights

Nov 17, 2017

Medical Affairs Reputations: Multiple Myeloma (US) 2016

Oct 30, 2017

Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid®

Jul 25, 2017

Bio Pharma Giant -- Celgene -- Settles Case Alleging Marketing Violations For $280 Million

Jun 08, 2017

Contergan Victim Wins Against Former Board Member of the Contergan Foundation